Loading the records…
Loading the records…
HR1931, the Access to Pediatric Technologies Act, is an early-stage House bill that would require CMS to establish Medicare payment methodologies for qualifying pediatric devices and drugs upon manufacturer request. The bill is referred to two committees with no further action in over a year. It authorizes no direct funding - it creates a regulatory pathway. For med-tech and pharma companies with pediatric product lines (JNJ, ABT, MRK, PFE), the bill is directionally positive but procedurally distant from becoming law.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
No immediate market implications. The bill is stuck in committee with no hearings scheduled. The 30-day price action for JNJ (-6.24%), ABT (-10.36%), MRK (-6.05%), and PFE (-5.44%) reflects broader sector selling, not legislative catalysts. Investors should treat this as a long-term policy signal that pediatric device/drug reimbursement is on Congress's radar, not a near-term trading catalyst. A committee hearing or markup would be the first actionable signal of momentum.
On March 6, 2025, Rep. John Joyce (R-PA) introduced HR1931, the Access to Pediatric Technologies Act of 2025. The bill was referred to both the Energy and Commerce Committee and Ways and Means Committee. As of today (April 30, 2026), the bill remains in early committee stages with no hearings, markups, or floor votes. A companion bill S249 was introduced in the Senate and referred to Finance Committee. Legislative velocity is low - zero actions in 13+ months since referral.
The bill does not authorize or appropriate any funding. It creates a regulatory mechanism: upon request from a manufacturer, CMS must establish national relative value units under the Medicare physician fee schedule for a 'qualifying pediatric technology' - defined as a Medicare-covered, FDA-approved device that is predominantly used for pediatric patients. The payment methodology is developed using contractor pricing, claims data, and other information. This is permanent statutory authority, not a one-time funding allocation.
Structural winners are companies with existing or pipeline pediatric medical devices and drugs that are Medicare-covered. JNJ (pediatric surgical, orthopedic, and pharmaceutical products), ABT (pediatric nutrition, diagnostics, devices), MRK (pediatric vaccines, pediatric oncology), and PFE (pediatric vaccines, rare disease) would benefit from reduced reimbursement uncertainty. However, the impact is marginal for these diversified giants - pediatric-specific Medicare revenue is a rounding error on their total revenue. Pure-play pediatric med-tech companies (mostly private or very small) would be the most proportionally affected, but no public pure-play pediatric device companies exist on US exchanges.
Real market data shows all four tickers in a 30-day downtrend: JNJ -6.24% (current $227.35), ABT -10.36% (current $91.33 - near 52-week low of $90.72), MRK -6.05% (current $110.95), PFE -5.44% (current $26.26). These moves are driven by broader market and sector factors, not by this bill's prospects. The bill's early-stage status means zero market price impact to date.
Timeline: The bill requires committee hearings and a vote in both Energy & Commerce and Ways and Means before a House floor vote. Companion S249 needs Senate Finance Committee action. With no action in 13 months and the 119th Congress halfway through its two-year session (2025-2027), the probability of passage in this Congress is low. If reintroduced in the 120th Congress (2027-2029), the timeline resets.
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
Matched on shared policy language across AI analyses, with ticker & timing weight
To amend the Public Health Service Act to ensure that pediatric cancer experts are represented in State comprehensive cancer control coalitions, to direct the Secretary of Health and Human Services to establish a pediatric cancer advisory committee, and for other purposes.
Gabriella Miller Kids First Research Act 2.0
Emergency Medical Services for Children Reauthorization Act of 2024
PFIZER INC: $45.5M Department of Health and Human Services Contract Vehicle
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →